Skip to main content
logo
Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.16
-0.95 (-7.84%)
At close: Nov 10, 2026, 4:00 PM EST
11.17
+0.01 (0.09%)
After-hours: Nov 10, 2026, 6:18 PM EST

Intellia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-426.14-412.69-519.02-481.19-474.19-267.89
Depreciation & Amortization
14.7415.9210.298.987.576.89
Loss (Gain) From Sale of Assets
0.460.53-0.080.07-0.16-
Asset Writedown & Restructuring Costs
-2.52---55.99-
Loss (Gain) From Sale of Investments
11.96-4.96-6.22-19.2715.4110.54
Loss (Gain) on Equity Investments
---15.6311.081.33
Stock-Based Compensation
62.6980.22154.27134.0591.447.01
Other Operating Activities
---0.113.49-
Change in Accounts Receivable
3.55-0.9527.94-32.69-1.740.1
Change in Accounts Payable
-2.215.996.82.52-4.580.53
Change in Unearned Revenue
-21.27-28.11-22.08-2.78-63.46-31.36
Change in Other Net Operating Assets
3.5-50.68-0.79-19.5115.917.82
Operating Cash Flow
-355.17-394.74-348.88-394.09-333.29-225.03
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.9-1.13-5.78-13.99-13.56-12.76
Sale of Property, Plant & Equipment
0.36---0.15-
Sale (Purchase) of Intangibles
-----44.83-
Investment in Securities
16.76229.16131.35-17.36218.55-538.02
Investing Cash Flow
14.22228.03125.57-31.35160.31-550.78

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
231.66131.49185.75130.32582.96736.69
Other Financing Activities
-0.3-----
Financing Cash Flow
305.12131.49185.75130.32582.96736.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-35.84-35.22-37.57-295.11409.98-39.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-358.08-395.87-354.66-408.07-346.85-237.79
Free Cash Flow Growth
------
Free Cash Flow Margin
-677.06%-584.99%-612.78%-1124.94%-665.46%-719.41%
Free Cash Flow Per Share
-2.82-3.65-3.59-4.60-4.51-3.35
Levered Free Cash Flow
-167.19-233.29-133.38-268.21-256.18-69.57
Unlevered Free Cash Flow
-166.86-233.29-133.38-268.21-256.18-69.57

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-16.43-73.7511.88-52.45-53.87-22.9
SEC Filings: 10-K · 10-Q